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Abstract
Introduction: Enhanced characterization of sleep architecture, compared with routine polysomnographic metrics such as
stage percentages and sleep efficiency, may improve the predictive phenotyping of fragmented sleep. One approach
involves using stage transition analysis to characterize sleep continuity.
Methods and Principal Findings: We analyzed hypnograms from Sleep Heart Health Study (SHHS) participants using the
following stage designations: wake after sleep onset (WASO), non-rapid eye movement (NREM) sleep, and REM sleep. We
show that individual patient hypnograms contain insufficient number of bouts to adequately describe the transition
kinetics, necessitating pooling of data. We compared a control group of individuals free of medications, obstructive sleep
apnea (OSA), medical co-morbidities, or sleepiness (n=374) with mild (n=496) or severe OSA (n=338). WASO, REM sleep,
and NREM sleep bout durations exhibited multi-exponential temporal dynamics. The presence of OSA accelerated the
‘‘decay’’ rate of NREM and REM sleep bouts, resulting in instability manifesting as shorter bouts and increased number of
stage transitions. For WASO bouts, previously attributed to a power law process, a multi-exponential decay described the
data well. Simulations demonstrated that a multi-exponential process can mimic a power law distribution.
Conclusion and Significance: OSA alters sleep architecture dynamics by decreasing the temporal stability of NREM and REM
sleep bouts. Multi-exponential fitting is superior to routine mono-exponential fitting, and may thus provide improved
predictive metrics of sleep continuity. However, because a single night of sleep contains insufficient transitions to
characterize these dynamics, extended monitoring of sleep, probably at home, would be necessary for individualized clinical
application.
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Introduction
Numerous endogenous and exogenous factors influence wheth-
er sleep or wake is achieved, how long a given state is maintained,
and the reasons sleep architecture may become fragmented
[1,2,3,4]. Much effort has been invested in attempts to correlate
various polysomnogram (PSG) metrics with daytime symptoms,
with the goal of understanding (and promoting) those aspects of
sleep that contribute most to its recuperative properties. However,
correlations between daytime sleepiness and PSG metrics are not
always straightforward, due in part to inter-subject variability, the
subjective nature of the clinical complaints, and variations in an
individual’s tolerance to sleep disruption. The commonly em-
ployed Epworth Sleepiness Scale (ESS), for example, correlates
with subjective complaints of sleepiness but not with objective
measures obtained from Multiple Sleep Latency Tests [5,6].
Although the ESS score was correlated with the severity of
obstructive sleep apnea (OSA) in the large Sleep Heart Health
Study (SHHS) database, the absolute changes were small and even
the most severe OSA group had scores within the normal range
(,10)[7]. Other measurements have also been investigated as
predictors of daytime sleepiness, including fragmentation [8],
autonomic arousals [9], and EEG measurements of cortical
arousals associated with respiratory events in OSA patients [10].
A meta-analysis of the relationship between sleep fragmentation
and daytime function suggested the importance of the percentage
of stage NREM1 which may inversely relate to sleep continuity
[11]. However, other reports show little relationship of stage
NREM1 proportions with fragmentation [12,13]. Percentage or
proportion of a state does not contain information about the
number of transitions, or fragmentation, which may contribute to
some of the differences in reporting.
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lifetime refers to the length of time spent in a given stage, indicates
decreased stability of sleep in OSA patients in proportion to
severity of disease[14]. Importantly, when sleep bout duration is
considered in this dynamic sense (the distribution of time spent in a
state), OSA was shown to alter sleep architecture despite
unchanged ‘‘summary’’ PSG metrics, such as stage percentages
or total sleep time[15]. Decreased sleep stability, as measured by
transition probabilities and survival analysis of sleep runs (stage-
independent), was also demonstrated in Chronic Fatigue Syn-
drome patients[16,17]. Transition probability analysis also dem-
onstrated that sleep fragmentation seen in elderly patients was due
to more frequent awakenings, but the wake bouts were unchanged
in duration, suggesting that the transition back to sleep was
unaffected by age[18]. These studies increasingly suggest that
standard metrics of sleep architecture and fragmentation/arousal
can be complemented by assessing the distribution of stage
durations and transition probabilities, in hopes of providing better
correlations with disease states and clinical symptoms.
Given the increasing realization that the percentage of time in a
given stage may be less important than their distribution dynamics
across the night, several groups have considered sleep architecture in
terms of the statistical distributions of sleep stage durations. In fact,
measurements of sleep in rodents, cats, and humans suggested that
the duration of sleep bouts appear to follow mono-exponential
kinetics, with species-specific time constants governing the time spent
in a given bout of sleep[19,20]. However, the mono-exponential
models often did not fit well over the entire range of bout durations,
suggesting that a more complex model may be required. Wake bout
duration kinetics remain controversial, being described as either an
exponential process[21], or a power law process[19,20,22]. Whereas
exponential distributions imply stochastic (probabilistic) state transi-
tions characterized by a time constant of ‘‘decay’’ or exit from a
particular state, a power law distribution implies a so-called scale-free
(or fractal) process, with no characteristic time scale of measurement.
Connecting the rapidly growing basic science understanding of sleep-
and wake- promoting brain centers to the behavioral manifestation of
arousal state transitions requires improved understanding of
transition dynamics. To accomplish this, we analyzed hypnograms
from the large SHHS database, to answer the following questions: 1)
what is the best model of sleep stage transition dynamics; 2) is a single
night of data sufficient for fitting and model discrimination; 3) how
does sleep fragmentation, such as that caused by OSA, alter the
temporal dynamics?
Our results demonstrate that multi-exponential fitting is
superior to routine mono-exponential fitting, but also show that
a single night of sleep contains insufficient transitions to
characterize these dynamics. Wake bout distributions may be
fitted by either a multi-exponential or a power law model. OSA
alters the dynamics by accelerating the decay of REM and NREM
bout durations, reflecting sleep fragmentation despite unchanged
summary metrics of state percentages.
Results
Characterizing sleep architecture dynamics
The summary statistics obtained from the PSG data for the
three patient groups are presented in Table 1. Note that despite
large differences in the AHI (1.8 vs 8.6 vs 47.4) and arousals, the
percent sleep efficiency and the N1 percentages were not different.
The differences in percentages of REM, N2 and N3 sleep did
reach significance: N2 showed a small increase in percentage
across mild and severe apnea; REM and N3 showed the inverse
pattern.
We examined the sleep architecture dynamics by focusing on
the distribution of bout durations of WASO, REM, and NREM
sleep. This was accomplished by generating frequency histograms
for each stage, a common technique that allows visualization of
data distributions, as well as fitting with functions such as
exponential and power law models. These plots are obtained by
collecting the relative number of events (y-axis) occurring in each
‘‘bin’’ (x-axis), defined here in single epoch increments of 30
seconds each. Figure 1 illustrates the frequency histograms of
WASO, NREM sleep, and REM sleep bout durations for the
control group. In these panels, ‘‘NREM’’ does not distinguish sub-
stage composition (that is, transitions within NREM sub-stages are
ignored, and NREM is taken as a single stage). Exponential fitting
of the duration distributions for each stage was performed (see
Methods). In each plot, the best fit single exponential function is
overlaid for visual inspection of goodness of fit. In addition, the r
2
values and the residuals (subtracting the fitted line from the data)
are shown in each case. Despite the high r
2 values (0.93–0.99),
visual inspection of the WASO, overall NREM sleep and NREM
sub-stage plots shows that the best single exponential function is
not adequate: it emphasizes the rapid decay phase (consisting of
brief events, which were more commonly observed) but entirely
misses the longer duration events (that occur less frequently).
Therefore, despite its common use (see, for example, ref [22]), r
2
values as a measure of goodness of fit should be used with caution
for such distributions. We show the traditional four NREM sub-
stages to determine possible differences in dynamics that could
explain the multi-exponential pattern seen in the global NREM
metric, although clinically it has been determined that stages 3 and
4 should be considered a single state (called N3). Therefore, for the
analysis shown in Figure 1, we assessed additional transitions not
currently recognized in the clinical scoring guidelines. The
number of NREM4 bouts was ,2% of total bouts in this control
cohort.
The residuals (Figure 1) provide an alternative view of how
different the fitted line is from the actual data, and it also reveals
why the r
2 values can appear statistically favorable (close to 1.0)
despite being visually sub-optimal. Although it appears that the
mono-exponential curve matches the fast decay but ignores the
slow decay, in fact the residuals demonstrate the opposite:
systematic deviations between the fitted line and actual data were
most prominent during the fast decay (short duration bins). The
absolute y-axis magnitude of the long duration ‘‘tail’’ is small, and
thus the residual between the fit and the data is small for the
majority of bin sizes, even though the fit completely misses this
portion of the bout distribution. Therefore, r
2 values remain high,
and overall residuals low, despite the sub-optimal single exponen-
tial fit. Assessing the normality of the residuals does not offer
clarification of this fitting issue, as the distribution of residuals fails
normality testing even for a single-exponential fit of 100,000
simulated bout durations drawn from a single exponential
distribution (not shown).
Next we compared the single-exponential fits against more
complex fits that included the sum of up to 4 exponential
functions. For each stage’s bout distribution, the fits were
compared pair-wise (1-vs-2, 2-vs-3, and 3-vs-4) using a sum-of-
squares F-test, as well as Akaike’s Information Criteria (AIC) (see
methods). For all stage distributions, these two metrics agreed on
the best number of exponentials required to fit the distribution.
For WASO and NREM distributions, the best fit was obtained
with the sum of 3 exponential functions, while for REM, the best
fit was the sum of 2 exponentials (Table 2). The fits for NREM
sub-stages (NREM1-NREM4) are shown in Table 3, for
comparison. Clearly the 3 exponentials of the NREM bouts
Sleep Architecture Dynamics
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mono-exponential substages, since 2-exponential fits were required
for NREM1-NREM3. Sample size considerations for fitting of
frequency distributions.
We also fit randomly selected subsets of the control group to
address the following questions: 1) Does the appearance of
multiple exponential functions imply heterogeneity within the
control group; and, 2) how different are the resulting fit
parameters when the sample size is decreased by more than a
factor of 10? The frequency histograms of four randomly selected
groups of 30 control individuals are shown in Figure 2. The
overlaid best fit single exponential function is visually sub-optimal
in these subsets, similar to fits of the full datasets seen in Figure 1.
The optimal number of exponentials was 2 (instead of 3 found for
the full dataset) for WASO across all four groups. The optimal
number of NREM exponentials was 3 for three of the four groups,
and 2 exponentials were optimal for the REM distributions across
all four groups (similar to the full dataset). The failure to detect the
third exponential from the WASO may be related to the very
small relative proportion of these long-duration events.
When only a single night of stage data was considered, the
frequency histograms were clearly under-sampled: fitting showed
variability between individual patients (Figure 3A), and for REM
bouts, convergence was often not possible. The distribution of
WASO, NREM, and REM sleep bout lengths is plotted for four
randomly selected individuals from the control group, illustrating
that variability arises when events are under-sampled (Figure 3B-
D). Interestingly, these single-night data sets may even appear to
Table 1. Group demographics and sleep-related data.
Variable Control Mild OSA Severe OSA
ANOVA
F(2, 1207), p Tukey
N 376 496 338
Age 68.266.3 63.8610.3 63.7610.5 30.43, ,0.001 1.2, 3
Sex (% males) 35.6 60 70.7 * 95.5, ,0.001
Race (% Caucasian) 85.4 73.8 74.3 *7.91, ,0.001
BMI (kg/m
2) 26.364 30.165.4 32.465.8 128.5, ,0.001 3.2,1
2.1
Anti-HTN use (%) 0 53.6 54.4 *178.8, ,0.001
Systolic BP (mm Hg) 125.2617.2 129.1619.2 131.7619.4 10.7, .0.001 2.1
3.1
3.2
Diastolic BP (mm Hg) 70.6610.2 74.2610.6 78.2613.1 40.4, ,0.001 3.1,2
3.2
Diabetes (%) 0 9.5 5.9 * 3.54, 0.06
Angina (%) 0 9.5 9.5 * 51, ,0.001
Myocardial infarction (%) 0 10.9 7.1 * 47.7, ,0.001
CHF (%) 0 2.6 1.8 * 24.9, ,0.001
ESS 4.962.2 13.162.8 9.864.9 610.6, ,0.001 2.1,3
3.2
Sleep efficiency (%) 81.2611.1 81.7610.2 79.4611.2 2.38, 0.09 N.A.
Sleep Latency (min) 22.7623.9 23.1622.5 22.9621.4 0.02, 0.9 N.A.
Total sleep time (min) 360664.8 326.5661.9 344.2661.7 53,9, ,0.001 1.2,3
3.2
N1 (%) 5.864.2 5.864.3 6.465.1 2.5, 0.08 N.A.
N2 (%) 54.9611.9 59.3610.7 63.1611.9 44.7, ,0.001 3.1,2
2.1
N3 (%) 19612.3 15.5611.4 13.2611.2 22.2, ,0.001 1.2,3
2.3
REM (min) 20.365.8 19.466 17.366.4 23.2, ,0.001 1.3
2.3
REM latency (min) 85.2653.7 86656.4 102.6669.3 8.81, ,0.001 3.1,2
Arousal index – total 17.368.6 1968.9 36.4616.4 302.3, ,0.001 3.1,2
Arousal index – NREM only 18.269.3 19.769.6 38617.3 284.2, ,0.001 3.1,2
Arousal index – REM only 13.668.7 15.769.7 27.3616.8 135.1, ,0.001 3.1,2
2.1
RDI 23.6614 36.3613.5 71.9617.2 1020.2, ,0.001 3.1,2
2.1
AHI 1.861.4 8.662.5 47.4616.4 2795.3, ,0.001 3.1,2
2.1
*Pearson Chi
2 95.5.
Values are mean 6 SD. BMI, body mass index; CHF, congestive heart failure; BP, blood pressure; HTN, hypertension; ESS, Epworth Sleepiness Scale.
doi:10.1371/journal.pone.0011356.t001
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statistical under-sampling of exponential processes, we simulated
sleep bout durations drawn from a mono-exponential distribution:
6 of 10 sampling trials passed normality testing when the number
of events was 10 per trial (Figure 3E), while only 2 of 10 trials
passed normality testing when the number of events per trial was
30 (Figure 3F), and none passed when the number of events per
trial was .75 (not shown). These results illustrate a major
statistical concern regarding attempts to describe bout distribu-
tions with insufficient samples (such as a single night of sleep).
The effect of OSA on sleep architecture dynamics
The optimal number of exponential functions was 3 for NREM,
and 2 for REM bout durations, regardless of apnea presence or
severity. The optimal exponential fits are shown for NREM and
REM bouts across all three cohorts in Figure 4. For NREM and
REM bout durations, the analysis detected significant differences
not only in the time constants associated with the exponential
functions, but also in their relative contributions, as indicated by
the y-axis intercept of each component. For example, the faster
overall decay of the REM bout distributions with OSA was
attributed to faster time constants (particularly of the fast
exponential) as well as an increase of the relative contribution of
the fast component (at the expense of the slow component). The
changes in bout distribution dynamics was not accounted for by a
change in the representation of males versus females in the control
versus OSA groups (Supplemental Material, Table S1). Although
we did not match the groups for other factors such as medications
or medical illness, which may also affect sleep architecture, the
pattern of REM . NREM fragmentation illustrated by our
analysis fits well with the hypothesis that sleep apnea accounts for a
large part of the observed changes in transition dynamics.
Given the common practice of fitting single exponential
functions to sleep-wake bout duration data, we calculated how
the weighted decay time constants (weighted according to their Yo
values) from our multi-exponential fits would compare to this
technique of fixed single exponential fitting. The weighted time
constants of the REM sleep multi-exponential decays were 12.8,
8.6, and 4.5 epochs for control, mild OSA, and severe OSA,
respectively (single exponential fits: 14.6, 10.8, 4.8 epochs,
respectively). The weighted NREM sleep multi-exponential decays
were 4.7, 2.9 and 2.4 epochs, respectively (single exponential fits:
Figure 1. Frequency histogram analysis of bout durations in the control group. The relative frequency of bouts in the control group is
plotted against the duration of bouts (in bins of 30-second increments on the x-axis) for WASO (A), NREM (B), REM sleep (C) and sub-stages of NREM
sleep (D) bouts. In each panel, the best fit single-exponential function (red) is overlaid, and the residuals (difference between data and fit) are plotted
beneath each histogram.
doi:10.1371/journal.pone.0011356.g001
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similar to the values obtained for the best single exponential fit to
the data. OSA clearly affects the best fit mono-exponential time
constant (whether by forcing a mono-exponential fit or by
calculating a weighted average of a multi-exponential fit).
Although mono-exponential fitting can distinguish sleep architec-
ture in the control cohort versus mild OSA and severe OSA, our
intention here is not to suggest exponential fitting as a diagnostic
tool for detecting OSA, but rather to illustrate the complex
dynamics underlying sleep fragmentation, using OSA as a prime
example of such pathological architecture.
Fitting frequency histograms with the power law
function
Several groups have reported that wake bout durations are
best described by a power law[19,20,22]. We therefore
performed power law fitting of the control and OSA frequency
histograms of WASO (Figure 5). While a linear appearance on
log-log plotted data suggests a power law process, such linearity
should be considered necessary but not sufficient. For example,
although a single exponential decay appears downwardly
convex on a log-log plot (and linear on a semi-log plot), a
multi-exponential process may appear linear on a log-log plot.
This can be seen in the WASO bout distributions, for the entire
control population (Figure 5A) and a randomly chosen 30-
p a t i e n ts u b s e t( F i g u r e5 B ) ,w h i c ha p p e a rl i n e a ro n a log-log plot
but are also well-fit by a 3-exponential process. However, the
true underlying distribution of wake bouts is of course not
known. Therefore, given the uncertainty, we generated
simulated bouts whose lengths were drawn from three known
exponential distributions to answer the question: can a known
multi-exponential function appear linear (that is, power-law-
like) on a log-log plot?
Parameters were chosen to imitate the actual time constants and
relative proportions seen in the fitting of the WASO distributions in
the control population. This simulation procedure was repeated
using three sample sizes that differed by a factor of 10, the largest of
which was similar to the total pooled sample size for WASO in
the control group. This dataset visually resembled a power
law distribution, appearing linear on the log-log plot shown in
Figure 5C. The power-law fitted function is also shown
in Figure 5C, and the 3-exponential fit is shown for comparison
in Figure 5D. Formal comparison between a power law and 3-
exponential function revealed that the 3-exponential function was
favored for n=1000 and n=10,000 samples, while the best
function was ambiguous for n=100. For the comparison between a
power law and the sum of two exponential functions, a power law
was favored for n=100 and n=1000 (two-exponential was favored
for n=10,000). The sum-of-squares and AIC methods differed in
some cases, a testament to the potential ambiguity associated with
choosing between different fitting functions, even when the samples
were known to be drawn from exponential distributions.
Discussion
This study complements and extends previous work on the
sleep-wake dynamics in several respects. First, sleep-wake state
transition probabilities are more complex than previously
recognized. The temporal stability of NREM and REM sleep
clearly requires more than a single-exponential function to
describe the bout distributions [19,20,23]. Second, our simulations
show that multi-exponential distributions may mimic a power law
distribution, the typical function used to describe wake bout
durations[19,20,22]. Third, we demonstrate that one night of data
is not an adequate sample of sleep-wake transitions to assess
transition dynamics statistically using this distribution fitting
method. Finally, we show that sleep fragmentation seen in OSA
Table 2. Exponential Fitting Parameters.
Control Mild OSA Severe OSA
WASO
Tau-Fast 0.60 (0.59–0.61) 0.53 (0.53–0.54) 0.53 (0.52–0.53)
% Fast 94.5% 93.2% 97.9%
Tau-Medium 3.1 (2.9–3.2) 2.2 (2.1–2.2) 3.7 (3.6–3.8)
% Medium 5.4% 6.5% 2.1%
Tau-Slow 16.1 (14.1–18.7) 14.6 (13.8–15.5) n/a
% Slow 0.3% 0.3% n/a
NREM
Tau-Fast 1.7 (1.6–1.8) 0.9 (0.8–0.9) 1.0 (1.0–1.1)
% Fast 77.3% 75.3% 82.8%
Tau-Medium 7.8 (6.9–9.0) 5.2 (4.9–5.5) 4.8 (4.6–5.1)
% Medium 18.2% 21.6% 15.2%
Tau-Slow 44.1 (40.0–49.1) 37.6 (35.2–40.3) 32.8 (30.6–35.4)
% Slow 4.4% 3.1% 2.0%
REM
Tau-Fast 3.8 (2.8–5.8) 2.6 (2.2–3.0) 1.9 (1.8–2.0)
% Fast 40.5% 57.5% 81.9%
Tau-Slow 19.0 (17.4–20.9) 16.8 (15.8–18.0) 16.3 (15.3–17.6)
% Slow 59.5% 42.5% 18.1%
Tau values (in units of ‘‘epochs’’) are given as mean with the 95% confidence
interval in parentheses.
doi:10.1371/journal.pone.0011356.t002
Table 3. NREM sub-stages.
NREM1
Tau-Fast 1.3 (1.1–1.4)
% Fast 93.8%
Tau-Slow 3.6 (2.1–11.5)
% Slow 6.2%
NREM2
Tau-Fast 1.1 (1.1–1.2)
% Fast 90.7%
Tau-Slow 10.8 (10.3–11.4)
% Slow 9.3%
NREM3
Tau-Fast 0.69 (0.67–0.71)
% Fast 94.0%
Tau-Slow 4.3 (4.0–4.6)
% Slow 6.0%
NREM4
Tau 0.79 (0.74–0.84)
Tau values (in units of ‘‘epochs’’) are given as mean with the 95% confidence
interval in parentheses.
doi:10.1371/journal.pone.0011356.t003
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sleep bout durations.
Clinical considerations regarding sleep stage transition
dynamics
Although it is common for sleep stages to be presented as the
average duration of time spent in wake, REM, or NREM sleep
stages, metrics such as mean and median may not be informative if
the distributions are not Gaussian, particularly if they are highly
nonlinear such as exponential or power law distributions. From a
‘‘biomarker’’ standpoint, the pattern and timing of stage
transitions may provide clinical insight into fundamental questions
about what it means to have ‘‘refreshing’’ sleep than summary
stage metrics, although this speculation remains to be tested. REM
sleep and SWS have been implicated in different types of learning
and memory[24,25], although the correlations of percentages of
these or other sub-stages with subjective daytime symptoms or
objective sleepiness is typically modest when present at all, as
Figure 2. Frequency histograms of random control subgroups. The relative frequency of bouts from four groups of n=30 randomly chosen
individualsselectedfromthecontroldataset. Eachrowrepresents adifferent group.The relativefrequencyofbouts is plottedagainstthedurationo fb o u t s
(30-second epoch bins) for WASO (column A), NREM (column B) and REM sleep (column C) bouts. The best single exponential fit is overlaid in red.
doi:10.1371/journal.pone.0011356.g002
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important, and accurate characterization of stage stability (by
virtue of bout duration or transition probability fitting) is an
important step in this direction. Given the wide spectrum of
subjective daytime symptoms (and poor correlation with objective
MSLT data) across different degrees of OSA[5,7], it is worth
considering these alternative tools to evaluate PSG data.
Whether different types of fragmentation occur in different
pathological states, or with different clinical symptoms, remains to
be explored. Although most of the published bout duration
analysis has focused on the presence or absence of OSA, recent
data suggests that sleep stage stability may be associated with
daytime symptoms in populations with syndromes of fatigue or
pain[16,17]. Non-refreshing sleep is a common complaint, with
Figure 3. Effects of under-sampling on analysis of bout duration distributions. The relative frequency histograms of WASO (A1) NREM (A2)
and REM sleep (A3) bout durations are shown for a single, randomly selected patient from the control group for comparison with histograms from
larger samples (Figures 1 and 2). The best single exponential fit is overlaid in red. Bout durations from four randomly selected individuals, are shown
in panels B–D, including the single patient shown in panels A1–3 (which corresponds to patient #4 in panels B–D), to illustrate how the distributions
can visually or statistically (asterisk) be mistaken as Gaussian. Under-sampling of simulated known monoexponential data leads to common mis-
classification of the distribution as Gaussian (E; asterisks), and such mis-classification decreases as the number of samples increases (F).
doi:10.1371/journal.pone.0011356.g003
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psychiatric domains[26,27]. Although initially proposed decades
ago, there is renewed interest in transition-based approaches to
quantify sleep architecture [14,15]. Indeed, if there are different
subtypes of fragmentation, or stage transition patterns are
important, summary PSG measures will miss these clues. Here,
and elsewhere[14,15], the pattern of stage stability is clearly
different in patients with or without OSA – despite minimal
differences apparent in summary statistics such as stage percent-
ages. From a fitting standpoint, our results demonstrate that
standard mono-exponential functions do not capture the bout
distribution dynamics of WASO, NREM or REM sleep. One
interpretation of the multi-exponential process is that there is a
balance between sleep stability and sleep satiation. For example,
some degree of instability is evident in the proportion of brief
events in the fitting, even in healthy control subjects. Longer
Figure 4. Multi-exponential fits of bout durations and the impact of mild versus severe OSA. Frequency histograms are shown for WASO
(A), NREM (B), and REM sleep (C) bouts. Control distributions (black) are compared with those of mild OSA (green) and severe OSA (red). To illustrate
visually the goodness of fit, the NREM (row D) and REM (row E) sleep histograms are shown separately, along with the time constants (tau) and %
contribution of each exponential function. For NREM sleep, the optimal number of exponentials was three, while for REM sleep, the optimal number
was two, regardless of OSA severity. Note the improved residual value patterns, compared to those of the mono-exponential fits from Figure 1.
doi:10.1371/journal.pone.0011356.g004
Sleep Architecture Dynamics
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of state. Satiation results in the culmination of stable sleep state by
increasing the tendency to awaken over time.
Our results also emphasize the requirement for sampling far
more than one night of sleep to adequately quantify bout duration
distributions. Cost and inconvenience prohibits more than one or
two nights of sleep in the laboratory setting for individual patients.
Whether improvements in home monitoring can offer an
alternative, which would allow longitudinal assessments of sleep
architecture for individual patients, remains to be explored.
Although the within-subject variability is likely less than between-
subject variability, the small number of transitions per night
suggests the importance of extended monitoring, likely in the
home setting.
Statistical considerations regarding bout duration
analysis
Statistical analysis of sleep stage percentages typically assumes a
Gaussian distribution, but some studies report mono-exponential
distribution of sleep bout durations [19,20]. We tested the
possibility that multiple exponential processes describe sleep-wake
stage distributions. The implication of multiple exponential
functions describing these distributions is that multiple transition
probabilities are involved. Although the ‘‘optimal’’ number of
Figure 5. Power Law analysis of WASO bout distributions. The WASO frequency histogram from the control group is shown in log-log display
(A), with the fitted power law overlaid in red. A 30-patient subset of WASO is shown in panel B for comparison. Various size samples drawn from three
simulated exponential distributions (with time constants of 1, 5, and 25 epochs, chosen to produce relative contributions in exponential fitting of
,95% fast, 4% intermediate, and ,1% slow) are shown in log-log plot (C) and linear plots (D) for comparison of exponential and power law fitting.
doi:10.1371/journal.pone.0011356.g005
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considerations, clearly the mono-exponential distribution is
insufficient. As seen at the biochemical level (for example, in
enzyme conformation switching or ion channel gating), the
duration of time spent in an observed or ‘‘phenotypic’’ state (such
as visually scored REM sleep) may demonstrate multiple
underlying rules or ‘‘generator’’ processes (such as may be
revealed by multi-exponential fits). Consider by analogy two
coins, one that is fair (heads arising with 50% probability), and one
that is unfair (say, 90% chance of heads), but the heads and tails of
each coin appear visually identical. Because each phenotypic state
(heads or tails) has two generators (one for the fair coin, one for the
biased coin),the distribution of repeated observations will include
contributions of both generator rules. In the same way, a visually
identified sleep stage (phenotypic state) may in fact be governed by
more than one generator process. Failure to recognize this
distinction (such as occurs when one employs a probability
matrix[23]) is equivalent to forcing a mono-exponential fit, and
may limit the potential ability to map fragmentation patterns to
clinical symptoms or pathology. Note that, in the case of NREM
bout durations, the 3-exponential fitting did not result from a
simple addition of mono-exponential NREM sub-stages; in fact
our data suggest that these sub-stages may themselves be governed
by multiple generators.
Our results identify an important statistical limitation in the
commonly employed r
2 value, which reports excellent (.0.9)
values despite largely missing the long tails of the distributions.
Moreover, analysis of residuals between the fitted curve and the
actual data, often used to test the goodness of fit, also under-
weights the poor fitting evident in the long tail events. This occurs
because of the relatively low probability of long events, yielding
small residual values even for forced mono-exponentials that miss
long events (see Figure 1).
Finally, although there is ongoing interest in fitting wake bouts
to a power law distribution, the distinction between a power law
and a multi-exponential distribution is not always straightforward.
Indeed, simulations showed that a known multi-exponential
process can visually and statistically resemble a power law. This
has mathematical implications for sleep transition modeling. For
example, if all sleep-wake bout durations are considered to be
exponential or multi-exponential, then all transitions of the
hypnogram may be simulated using a Markov chain model.
Although there are several limitations, the appeal of Markov
models is that stage transitions are considered probabilistic, and
certain transitions may be stabilized or destabilized by different
neural circuits or neuromodulators [22,28,29].
Physiological implications for exponential bout durations
The transition between sleep and wake (and between REM and
NREM sleep) has been compared to a ‘‘switch’’ consisting of
reciprocal inhibition between neurons whose firing favors one or
another state[2,30]. Indeed, optogenetic stimulation of orexin
neurons in transgenic mice increased the probability of transition
from sleep to wake[31]. Whether detailed transition analysis of
existing animal lesion studies targeting specific sleep- or wake-
promoting nuclei can shed additional light on the neural circuitry
underlying the transition probability dynamics remains to be seen.
From the standpoint of future sleep architecture ‘‘fingerprint-
ing’’, there is potential for use of Markov chain models[23,32,33],
the parameters of which could be extracted from sleep architecture
information. For example, disease states (or lesion sites) could be
associated with changes in the number of exponential functions
describing a given stage distribution, which stage transitions are
possible, and the probabilities governing each transition. Regard-
ing the homeostatic and circadian influences on state transition
probabilities, analysis of sleep dynamics in humans subjected to
forced desynchrony protocols may prove important. The ultimate
goal is to link sleep architecture patterns to anatomical,
physiological, behavioral, and pathophyisological aspects of sleep
and wake function.
Conclusion
Clinical correlations between daytime complaints and poly-
somnographic metrics of disease severity are not always straight-
forward, due in part to inter-subject variability, largely subjective
complaints, variable intrinsic tolerance to sleep disruption, and the
short duration and non-natural setting of routine clinical
monitoring. Even OSA-mediated fragmentation can be missed
in routine clinical metrics (such as stage percentages). The key
concept is that seemingly complex and variable manifestations of
‘‘fragmentation’’ may in fact possess objective and identifiable
underlying statistical structure, which may offer opportunity for
improved correlation with clinically relevant endpoints.
Materials and Methods
Database cohorts
Three groups of patients were selected from the Sleep Heart
Health Study, a large database of home-based polysomnography
(PSG) in over 6000 patients[34]. We have obtained Category IV
Institutional Review Board (BIDMC) approval for use of the data
obtained from this database, the data of which is anonymous and
thus we do not require additional consent. The pre-defined groups
included controls (defined as AHI,5, ESS,10, no medications
and no cardiovascular co-morbidities), and two groups with sleep
disordered breathing: mild OSA (AHI 5–15), and severe OSA
(AHI .30). The duration of time spent in any stage, measured in
units of 30-second epochs, was analyzed for each group, including
wake (after sleep onset; WASO), NREM1, NREM2, NREM3,
NREM4, and REM sleep stages. We also considered NREM as a
single stage in separate analyses (ignoring transitions between
NREM sub-stages). Note that for the clinical characteristics in
Table 1, we used the accepted clinical definitions of NREM sleep
sub-stages (N1-N3), but for the exponential fitting, we used the
traditional 4 stage classification, as originally reported in the
SHHS. Note also that we did not control statistically or attempt to
match the cohorts initially for differences in age, sex, medical
comorbidities, or medications (as was done for example in Swihart
et al[15]). Differences in these factors are illustrated in Table 1
(using Chi
2 or ANOVA as appropriate). Because of the larger
difference in M:F proportion across groups, we did re-analyze the
exponential fitting of the control cohort by sex (Supplemental
Material, Table S1). Although small differences are evident, the
change in proportion of M:F in the OSA groups does not account
for the observed differences reported in the main text. In
particular, for example, the REM bout durations, which show
the most marked impact of OSA, had similar parameters.
Bout duration analysis and curve fitting
All bouts of a given stage from each subject groups were
combined for statistical analysis. Frequency histograms of bout
durations were generated by Prism (GraphPad Software, LaJolla,
CA, USA). Bin width was one epoch. The relative frequency of
bouts in each bin was calculated, and the resulting histograms
were normalized to the maximal relative frequency (which was
always in the shortest bin) before fitting routines were undertaken.
All stage distributions, in each clinical group, failed three tests of
normality (D’Agostino-Pearson, Shapiro-Wilk, and Kolmogorov-
Sleep Architecture Dynamics
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decay function: Y = Yo *e
2kX + C, where Yo is the Y-intercept
value, k is the rate constant describing the rate of decay of the
function, X is the time (in units of epochs), and C is a plateau value
(which we forced to zero). Fitting constraints included positive k
values (required for a decay), and zero C value because there is no
biological reason to consider otherwise. For multiple exponential
fits, the equation involves a linear sum of i components defined by
[Yoi *e
2kiX] values, the Yo of which corresponds to the intercept of
each component. Although we refer to this term as the ‘‘relative
contribution’’ of that component, it reflects neither the number of
events associated with that time constant (which can far exceed the
coefficient proportion), or the area under the curve of that
exponential decay (which is biased against fast time constants).
Confidence intervals are shown to allow comparison of each
parameter between the three cohorts.
Goodness of fit was compared between the best single-
exponential function and the sum of i =2, 3 or 4 exponentials,
using in each case a non-linear sum-of-squares F-test (which
considers how well a fitted curve matches the data) and Akaike’s
Information Criteria (AIC) (which considers which of two
functions fits the data better, but does not consider the goodness
of fit per se), using built-in Prism routines. No weighting of residuals
was implemented (exponential fits did not converge if Y-value
weighting was used). Each function’s goodness of fit was compared
sequentially: 1 versus 2 exponential components, then 2 versus 3,
and so forth, until the additional component no longer
significantly improved the fit by F-test criteria, or the algorithm
failed to converge within 3000 iterations. Higher numbers of
exponentials were not tested because the sum of 4 exponentials
never provided a significantly better fit than 3 exponentials. The
optimal exponential fit was then compared with the fit provided by
a power law: Y = A * X
B, where A is a constant, X is time (in units
of epochs), and B is the ‘‘critical’’ or scaling exponent
characterizing the power law. This was also subject to both non-
linear sum-of-squares, and AIC criteria. Note that Prism fits the
function to the actual data, rather than fitting a linear regression to
the semi-log or to the log-log plotted data.
Simulations: The only simulated data appears in Figures 3 (D,
E) and 5. To generate simulated bout lengths, we used MatLab
(MathWorks, Natick, MA, USA): the ‘‘exprnd’’ function is a
random number generator following a single exponential distri-
bution specified by a time constant of decay; the ‘‘randsample’’
function was used to draw from the generated distributions. These
simulation bout lengths were exported for analysis in Prism as
above.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0011356.s001 (0.04 MB
DOC)
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